Miriam Weber

Dr. Miriam Weber

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
MWMiriam Weber
Miriam Weber
PMPauline M. Maki
Pauline M. Maki
MMMichael P. McDermott
Michael P. McDermott

1 May 2013 in Menopause
Verified
Journal Article
Closed access
MWMiriam Weber
Miriam Weber
LRLeah H. Rubin
Leah H. Rubin
PMPauline M. Maki
Pauline M. Maki
Objective The aims of this cross-sectional study were to determine if cognitive function differs across stages of reproductive aging and to evaluate whether hormones or menopausal symptoms predict cognition in perimenopause. We hypothesized that women in late menopausal transition and early postmenopause would perform more poorly than those in the late reproductive stage on attention and verbal memory tasks, and that estradiol, depressive symptoms, anxiety symptoms, hot flashes, and sleep disturbance would predict cognitive performance on those tasks. Methods One hundred seventeen middle-aged women enrolled in the Rochester Investigation of Cognition Across Menopause were categorized into late reproductive stage (n = 34), early menopausal transition stage (n = 28), late menopausal transition stage (n = 41), or early postmenopause stage (n = 14) according to criteria from the Stages of Reproductive Aging Workshop +10. We administered a neuropsychological battery assessing six domains of cognition, assessed menopausal symptoms, and measured serum levels of estradiol and follicle-stimulating hormone. Multivariate regressions were conducted to determine the impact of menopausal stage and symptoms on cognition. Results Women in the first year of postmenopause performed significantly worse than women in the late reproductive and late menopausal transition stages on measures of verbal learning, verbal memory, and motor function. They also performed significantly worse than women in the late menopausal transition stage on attention/working memory tasks. Conclusions Cognitive function does not change linearly across perimenopause. Decreases in attention/working memory, verbal learning, verbal memory, and fine motor speed may be most evident in the first year after the final menstrual period.

1 July 2012 in Menopause
Verified
Journal Article
Closed access
MWMiriam Weber
Miriam Weber
MMMark Mapstone
Mark Mapstone
JSJennifer Ma Staskiewicz
Jennifer Ma Staskiewicz
PMPauline M. Maki
Pauline M. Maki
Objective The overall aim of this study was to examine the relationship between subjective memory complaints and objective cognitive performance in perimenopausal women. The specific aims were to determine (1) if subjective complaints of memory problems relate to objective performance on memory tests, (2) if subjective complaints of memory problems relate to other domains of cognitive function, and (3) if subjective memory complaints relate to other noncognitive factors, such as depression, anxiety, and sleep quality. Methods Seventy-five perimenopausal women completed a comprehensive neuropsychological battery, which included measures of attention, working memory, verbal memory, verbal fluency, visuospatial skill, and fine motor dexterity; completed self-report inventories of their perceived memory and menopausal symptoms; and provided serum levels of estradiol and follicle-stimulating hormone. Results Memory complaints were not associated with verbal learning or verbal memory but were associated with working memory and complex attention/vigilance. Memory complaints were also associated with symptoms of depression, anxiety, somatic complaints, and sleep disturbance. Regression analyses revealed that memory complaints were best predicted by depressive symptoms, somatic complaints, and working memory performance. Conclusions Memory complaints in the menopausal transition may reflect true difficulties with attentionally mediated cognitive processes. Memory complaints may also be associated with other menopausal-related symptoms.

1 July 2009 in Menopause
Verified
Journal Article
Closed access
MWMiriam Weber
Miriam Weber
MMMark Mapstone
Mark Mapstone
Objective: The aim of this study was to examine the relationship between perimenopausal memory complaints and performance on objective neuropsychological tests. A secondary aim was to determine if putative deficits are related to other relevant factors, such as hormone levels, mood state, or sleep quality. Methods: Twenty-four perimenopausal women were enrolled. Participants completed questionnaires assessing mood, anxiety, menopausal symptoms, health, and subjective memory function. They also underwent comprehensive cognitive testing, which included measures of attention, working memory, verbal memory, verbal fluency, visuospatial skill, and fine motor dexterity. We obtained serum estradiol and follicle-stimulating hormone levels on the day of testing. Results: We found no association between memory complaints and performance on tests of retentive memory. However, memory complaints were associated with poorer memory encoding and increased depressive symptoms. Regression analyses revealed that memory complaints were best predicted by depressive symptoms, whereas encoding performance was predicted by depressive symptoms and estrogen level. Women with significant memory complaints performed worse on tests of encoding, after controlling for depression and sleep disturbance. Conclusions: These results suggest a complex relationship between mood, memory, and hormones that may underlie perimenopausal memory complaints. Furthermore, they suggest that some women may be particularly vulnerable to the subjective experience of memory problems and relative decreases in attentionally mediated cognitive function.

24 March 2021 in Climacteric
Verified
Journal Article
Closed access
MWMiriam Weber
Miriam Weber
LRL. H. Rubin
L. H. Rubin
RSR. Schroeder
R. Schroeder
TST. Steffenella
T. Steffenella
PMP. M. Maki
P. M. Maki
Perimenopause is associated with declines in attention, working memory and verbal memory; however, there are significant individual differences. Further, the contributions of hormones and menopausa... 目的:围绝经期与注意力、工作记忆和言语记忆下降有关。然而存在显著的个体差异。此外, 激素和更年期症状对特定领域认知功能的影响仍不清楚。这项纵向研究目的是确定围绝经期是否有不同的认知特征, 并确定与每个认知特征相关的因素。设计:在 85 名女性中评估了 400 多个两年一次的访问, 我们对其进行了全面的神经心理学检查以评估更年期症状, 并测定了17β-雌二醇和卵泡刺激素。多级潜在剖面分析用于识...

6 September 2022 in Neurology
Verified
Journal Article
Closed access
PDF file
MWMiriam Weber
Miriam Weber
AFAlan Finkelstein
Alan Finkelstein
NUNasir Uddin
Nasir Uddin
ERElizabeth Asiago Reddy
Elizabeth Asiago Reddy
RARoberto C. Arduino
Roberto C. Arduino
GSGiovanni Schifitto
Giovanni Schifitto
Background and Objectives While combination antiretroviral therapy (cART) has dramatically increased the life expectancy of people with HIV (PWH), nearly 50% develop HIV-associated neurocognitive disorders. This may be due to previously uncontrolled HIV viral replication, immune activation maintained by residual viral replication or activation from other sources, or cART-associated neurotoxicity. The aim of this study was to determine the effect of cART on cognition and neuroimaging biomarkers in PWH before and after initiation of cART compared with that in HIV-negative controls (HCs) and HIV elite controllers (ECs) who remain untreated. Methods We recruited 3 groups of participants from the University of Rochester, McGovern Medical School, and SUNY Upstate Medical University: (1) ART treatment–naive PWH; (2) age-matched HCs; and (3) ECs. Participants underwent brain MRI and clinical and neuropsychological assessments at baseline, 1 year, and 2 years. PWH were also assessed 12 weeks after initiating cART. Volumetric analysis and fractal dimensionality (FD) were calculated for cortical and subcortical regions. Mixed effect regressions examined the effect of group and imaging variables on cognition. Results We enrolled 47 PWH, 58 HCs, and 10 ECs. At baseline, PWH had worse cognition and lower cortical volumes than HCs. Cognition improved after initiation of cART and remained stable over time. Greater cortical thickness was associated with better cognition at baseline; greater FD of parietal, temporal, and occipital lobes was associated with better cognition at baseline and longitudinally. At baseline, ECs had worse cognition, lower cortical thickness, and lower FD in all 4 lobes and caudate than PWH and HCs. Greater cortical thickness, hippocampal volumes, and FD of frontal, temporal, and occipital lobes were associated with better cognition longitudinally. Discussion Initiation of cART in PWH is associated with improvement in brain structure and cognition. However, significant differences persist over time when compared with HCs. Similar trends in ECs suggest that results are due to HIV infection rather than treatment. Stronger associations between cognition and FD suggest this imaging metric may be a more sensitive marker of neuronal injury than cortical thickness and volumetric measures.